Development Office Funding Opportunities

The Development Office’s Corporate and Foundation (C&F) Team identified the below funding opportunities. To apply, please contact DevCorpFound@mountsinai.org. The C&F team will help plan, write, and submit your application.
 Alzheimer’s Association: The Tau Pipeline Enabling Program (T-PEP) IV Amount: Up to $750,000 over 1-2 years

Deadline:
•LOI due May 28, 2026
•Full application due August 14, 2026

Eligibility:

•Academic institutions, nonprofit organizations, and small for-profit companies may apply. Preference is given to companies with 50 or fewer employees.

•The principal investigator must be considered a full-time employee of the applicant organization. Postdoctoral applicants are not eligible to serve as PI but may be included as key personnel.Academic institutions, nonprofit organizations, and small for-profit companies may apply. Preference is given to companies with 50 or fewer employees.

About: The Tau Pipeline Enabling Program (T-PEP) seeks to accelerate the discovery of potential new therapies for tauopathies. This program intends to enrich the pipeline for therapy development by facilitating the translation of academia-derived ideas into practical application. In short, T-PEP bridges the gap between innovative but resource-constrained researchers and the larger pharmaceutical companies that are looking for drug candidates to be taken into human trials.

The overarching goal of T-PEP is to promote the advanced study of a wide range of novel targets, agents, and/or therapeutic strategies that will accelerate the development of disease-modifying interventions for tauopathies.

https://www.alz.org/research/for_researchers/grants/types-of-grants/tau-pipeline-enabling-program-v
Male Contraceptive Initiative: 2026 RFP Amount: Up to $400,000 over 2 years

Deadline:
•LOI due May 30, 2026
•Full proposal due August 30, 2026

Eligibility:

•This application is open to global academic institutions, for-profit organizations, and other entities. Any individual(s) with the skills, knowledge, and internal or external resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to submit an application through their institution.

Core Grants support research projects in discovery, nonclinical, and clinical development of reversible non-hormonal male contraceptives. All modalities are eligible: small molecules, biologics, devices, and other approaches. Projects may range from target validation and screening through IND-enabling studies and early clinical work. Envisioned eligible project activities include but are not limited to:

•Discovery & Target Validation: Studies to identify and validate novel targets for male contraception. Research on the biology of sperm development, maturation, and function to identify potential points of intervention. Development of assays and screening platforms.

•Hit-to-Lead & Lead Optimization: High-throughput screening and medicinal chemistry to identify and optimize lead compounds. Structure-based drug design and SAR studies. In vitro assessment of ADMET properties. Chemical modifications to enhance potency, selectivity, or pharmaceutical properties.

•Preclinical Development: Preclinical studies (in vitro and in vivo) to assess safety and efficacy. Pharmacokinetic/pharmacodynamic (PK/PD) studies in relevant animal models. Development of formulations and novel drug delivery systems (e.g., long-acting injectables, implants, transdermal systems). Toxicology and safety pharmacology studies. Manufacturing process development at research scale.

•Clinical Development: IND-enabling studies and regulatory interactions. Phase 1 and Phase 2 clinical trials.

•Devices & Biologics: Design, prototyping, and testing of contraceptive devices. Development and optimization of biologics (e.g., antibodies, peptides). ISO compliance work for devices.

•Other Approaches: Repurposing existing drugs for contraceptive use. Development of multipurpose prevention technologies (MPTs). 

https://www.malecontraceptive.org/funding-opportunities.html
ADDF-Harrington Scholar Program Amount: $600,000 over 2 years Deadline:
• LOI due June 1, 2026
• Full proposal due August 17, 2026

Eligibility:

• Lead investigator must have an MD, a PhD, or equivalent.
• Proposals should show potential to advance discovery into meaningful therapeutics to treat, prevent, slow, or reverse Alzheimer’s disease or related dementias (vascular dementia, frontotemporal dementia, Lewy Body dementia, LATE etc).
• Team should possess intellectual property (IP) or have potential for novel IP that has not yet been licensed to a for-profit entity.
• Researchers working on drug development programs that are relevant to but not presently focused on the Alzheimer’s field are strongly encouraged to apply.

About: The ADDF-Harrington Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This award provides funding and project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and the Brain Health Medicines Centers of the Harrington Discovery Institute. ADDF-Harrington Scholar Program | Alzheimer’s Drug Discovery Foundation
American Cancer Society: Clinician Scientist Development Grant Amount: $675,000 over 5 years Deadline: June 1, 2026

Eligibility:

• Have a doctoral degree, an active clinical license, and participate in clinical care
• Are not a current or former principal investigator (PI) of an individual mentored training grant
• Have NOT had an R-level or equivalent grant as PI

About: The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. Clinician Scientist Development Grant | American Cancer Society
American Cancer Society: Postdoctoral Fellowships  Amount: Up to $204,000 over 3 yrs  Deadline: June 1, 2026 

Eligibility: 
You are eligible to submit a proposal if you:
Have had your doctoral degree for LESS than 4 years; time spent in clinical-only training is not counted.
Do not have a faculty appointment (e.g., Instructor, Research Assistant Professor)

About: Postdoctoral Fellowships (PF) support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.  https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/postdoctoral-fellowships.html
American Cancer Society: Research Scholar Grants Amount: $860,000 over 4 yrs Deadline: June 1, 2026

Eligibility:

You ARE eligible to submit a proposal if you:
• Were first appointed as independent, full-time faculty LESS than 10 years ago
• Are the PI on NO MORE than 1 R01 or R01-equivalent grant at the time of application

About: Research Scholar Grants (RSG) provide support for independent, self-directed researchers. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research area. Cancer Research Scholar Grants | American Cancer Society
American Cancer Society: Stage I Mission Boost Amount: Stage I Mission Boost: Up to $270,000 over 2 yrs Deadline: June 1, 2026 

Eligibility:

•No longer require MBG applicants to be current or former ACS grantees or fellows.
•Are an independent investigator with a full-time faculty appointment (or equivalent). Applicants may be at any career stage.
•Applicants may submit only one MBG I or MBG II application per cycle, and applicants may not submit RSG, DBG, or CSDG applications in the same cycle as a MBG submission.

About: Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects. Stage I requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients.  https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/mission-boost-grants.html
American Cancer Society: Stage II Mission Boost  Amount: Stage II Mission Boost: Up to $545,000 over 1.5 yrs  Deadline: June 1, 2026 

Eligibility:

You are eligible to submit a proposal if you:
• Have an independent, full-time faculty appointment
• Previously held or currently hold a Stage I Mission Boost Grant for a minimum of 18 months AND have completed Stage I milestones

About: Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects. Stage II supports testing in cancer patients. Mission Boost Grants | American Cancer Society
Rheumatology Research Foundation: Career Development Bridge Funding Award – K Bridge Amount: Up to $75,000 over 1 year

Deadline:
•Full application due June 1, 2026

Eligibility:
Applicant must be an ACR or ARP member at the time of submission and for the duration of the award

• ACR Members:
o Applicants must have received a priority score and summary statement on their NIH K08, K23, K25, K99/R00, or VA CDA-2 award. Applicants whose career development applications were unscored are not eligible.
o Have earned a DO, MD, MD/PhD, or DO/PhD degree or be currently enrolled in an ACGME accredited clinical training program and have completed at least 1 year of training by the start of the award term

• ARP Members:
o Applicants must have received a priority score, summary statement, and funding decision on their on their NIH K01, K08, K23, K25, K99/R00, or VA CDA-2 award. Applicants whose career development applications were unscored are not eligible.
o Have earned a PhD*, DSc, or equivalent doctoral degree

About: The purpose of this award is to provide bridge funding for promising investigators as they are revising outstanding individual career development award applications (i.e., applications for NIH K series awards, VA CDA-2 awards, or any equivalent career development awards). Through this bridge funding award, the Foundation will support junior faculty members so that they have the highest likelihood of achieving success in obtaining longer term career development awards

Highlighted Topic: Psoriatic Arthritis
Through a generous contribution by Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN), funding for one Career Development Bridge Funding Award: K Bridge has been provided for research focused on advancing the understanding and treatment of psoriatic arthritis.

Career Development Research Awards | Rheumatology Research Foundation
Rheumatology Research Foundation: Career Development Bridge Funding Award – R Bridge  Amount: Up to $200,000 over 2 years  Deadline:
•LOI due May 20, 2026
•Full proposal due September 9, 2026

Eligibility:
Applicant must be an ACR or ARP member at the time of submission and for the duration of the award

• ACR Members:
o Applicants must have less than 1 year (or a lapse) remaining on one of the following awards: NIH K08, K23, K25, K99/R00, VA CDA, institutional K, or Rheumatology Research Foundation Investigator Award.
o Have earned a DO, MD, MD/PhD, or DO/PhD degree and have completed a Rheumatology fellowship.

• ARP Members:
o Applicants must have less than one year (or a lapse) remaining on one of the following awards: NIH K01, K08, K23, K25, K99/R00, VA CDA, institutional K, or Rheumatology Research Foundation Investigator Award.
o Have earned a PhD*, DSc, or equivalent degree.

About: The purpose of this award is to provide funding to NIH R01, VA Research Career Scientist (RCS) or Merit Award applicants whose application received a priority score but was not funded, and who are at risk of running out of research support.  Career Development Research Awards | Rheumatology Research Foundation
Crohn’s & Colitis Foundation Senior Research Award Amount: Up to $390,000 over 3 years Deadline:
•LOI due June 2, 2026
•Full proposal due July 23, 2026

Eligibility:

•Applicant must hold an MD and/or PhD (or equivalent degree) and must be employed by an institution (public non-profit, private non-profit, or government) that is engaged in health care and/or health-related research. He/she must have attained independence from his/her mentor.
•Proposal must be relevant to Inflammatory Bowel Disease (IBD) or Crohn’s disease and/or ulcerative colitis. Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Training Award is not permitted.

About: Provides established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources such as the National Institutes of Health (NIH). https://www.crohnscolitisfoundation.org/research/grants-fellowships/senior-research-awards
AACR-Novocure Cancer Research Grant  Amount: $350,000 over 3 years  Deadline: Proposal due June 4, 2026 

Eligibility:

•Applicants must be AACR Active members who are independent investigators and have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. 

About: Supports independent investigators who are currently conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage independent investigators to enter the TTFields research field. The Inovitro® system (which will be provided by Novocure, if needed), must be included in the experimental design.
Research projects should examine the use of TTFields as a therapeutic modality for cancer. Proposals may include 1) Basic and translational approaches, promoting the transition of TTFields in vitro work into in vivo systems, 2) Studies that link preclinical and clinical data, or 3) Studies with ability to translate into the clinic for cancer treatment.
Projects that focus on one or more of the areas outlined below are strongly encouraged, provided they incorporate the use of Inovitro® and/or inovivo® systems:
• Key cancer-related signaling and cellular pathways.
• Metabolic effects of TTFields.
• Studies that include Omics data (genomics, transcriptomics, proteomics).
• TTFields immunological aspects and the potential combination with immunotherapy.
• Combinational studies with approved agents (preferably to include mechanistic aspects).

AACR-Novocure Cancer Research Grant | Grants| AACR
SPARK NS Translational Research Program  Amount: Stage II Mission Boost: Up to $545,000 over 1.5 yrs  Deadline: June 5, 2026 

Eligibility: —

About: SPARK NS is an independent non-profit translational research organization dedicated to efficiently advancing promising neuroscience discoveries from the lab to the clinic.

For the SPARK NS Translational Research Program, 2026 Cohort, SPARK NS will select academic PIs with therapeutic discoveries in Parkinson’s disease or autism at any stage of development between target identification and entry into clinical trials. For selected projects, SPARK NS will provide funding, education, mentorship, and networking opportunities focused on advancing the translation of novel science to first-in-class therapeutics.

Proposed projects must:
• Address an unmet clinical need in Parkinson’s disease or autism
• Use a robust and novel approach
• Have a high probability of success at accomplishing proposed translational objectives

SPARK NS Call for Proposals
ChadTough Fellowship Grant Amount:
•Predoc – $200,000 over 3 years
•Postdoc – $300,000 over 3 years
Deadline:
•LOI due June 8, 2026
•Full proposal due September 2, 2026

Eligibility:
•For pre-doctoral applicants:
Applicant must be enrolled in a research doctoral degree program at an accredited academic institution.

•For post-doctoral applicants:
Applicant must hold an M.D. and/or Ph.D. by the application deadline.
Applicant must be no more than 6 years post-completion of last degree.

About: The ChadTough Defeat DIPG Fellowship Grant is intended to attract and support promising scientists embarking on careers involving DIPG research. By providing funding to outstanding fellows under the guidance of a mentor, we seek to assist in the development of the next generation of leaders in the field of DIPG research. https://media.chadtough.org/wp-content/uploads/2025/05/06125321/2025-Fellowship-Application-Guidelines-1.pdf
The Jacobs Foundation: LEVANTE  Amount:
•Regular projects: Up to $250,000 over 3 years
•Larger Projects: Up to $600,000 over 4 years
•Infrastructure Projects: Up to $1M over 4 years
Deadline:
LOI due June 10, 2026

Eligibility:

•Have obtained a PhD or equivalent degree at least 5 years (excluding career breaks) prior to the application deadline; 

•Be employed by and be part of a research lab at an institution of higher education or research institute;

•Be conducting high-quality research in the area of variability of learning and development;

•Be committed to engaging with and contributing to the activities of both LEVANTE and the Jacobs Foundation.

About:  The overarching objective of LEVANTE is to identify how individual variability, group heterogeneity, and contextual variability influence children’s learning and development. By including data collection of common measures on these different areas longitudinally and at a global level, LEVANTE will help researchers, educators, and policymakers understand child development within individuals, within groups, and across contexts, thus improving future learning outcomes for diverse groups of children worldwide. The focus of the Jacobs Foundation is fostering scientific excellence and building a strong network of internationally active researchers in the field of child and youth development with a strong focus on variability of learning and to foster long-term collaboration with other researchers and the Jacobs Foundation.

This call seeks proposals for research projects that collect longitudinal data using the LEVANTE battery across ages 3–12. Within this framework, special consideration will be given to proposals that

•Contribute to causal inference on mechanisms underlying learning and development, and/or generate insights into how environmental and contextual factors shape learning
•Strengthen the use of innovative, high-resolution measurement approaches and/ or advance our understanding of within-child variability and developmental trajectories

https://levante-network.org/open-call-for-proposals-2026/
American Society of Transplantation: Transition to Independence Research Grants Amount: Up to $150,000 over 2 years 

Deadline: June 15, 2026

Eligibility:
The applicant (MD, PhD, PharmD, or equivalent) must hold an academic faculty appointment and be developing an independent research program
Applicants cannot be a PI on a previous or current NIH grant to perform independent research.
Applications are accepted in basic, clinical, and translational research. Only applications supporting research directly related to solid organ transplantation will be considered.

About: The purpose of the AST Research Network Transition to Independence Research Grants is to promote the careers of academic investigators whose development of an independent research program is focused on the field of basic science, translational and clinical investigation in solid organ transplantation. The grants are intended to provide support for the investigator’s transition to an R-series or equivalent grant. The Transition to Independence Research Grant seeks to:
•Foster the transition of early to mid-career scientists who are contributing to our understanding of transplant science/immunobiology and/or treatment of transplant recipients and need funding to start or strengthen work that is not yet funded by larger grants.
•Foster research that is of high merit.
•Encourage the continued commitment of high-quality applicants to careers in academic transplantation About: Postdoctoral Fellowships (PF) support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.  
https://www.myast.org/grant-opportunities/transition-independence-grants
Glaucoma Research Foundation: Shaffer Grant for Innovative Research  Amount: Up to $55,000 over 1 year

Deadline:
• LOI due July 15, 2026
• Full proposal deadline TBD

Eligibility:

• Grant applicants must possess a graduate degree
• Must not have received a Shaffer Grant within the prior three years

About: Supports young investigators with new perspectives to treat and cure glaucoma. There are two primary focus areas that this grant will fund:

1.Physiology of Glaucoma: May include projects to protect and restore the optic nerve, accurately detect glaucoma and monitor its progress, provide better understanding and treatment for congenital/juvenile glaucoma, understand the intraocular pressure system and develop better treatments, and determine the risk factors for glaucoma damage using systematic outcomes data.

2.Genetics of Glaucoma: May include projects to identify the genes that cause glaucoma and explore new approaches to gene therapy to preserve or restore vision 

Apply For A Grant – Glaucoma Research Foundation
LAM Foundation Pilot and Feasibility Grant Amount:  $100,000 Deadline:
•LOI due June 15, 2026
•Full proposal due September 15, 2026

Eligibility:

An applicant may be a postdoctoral research fellow, postgraduate medical trainee, junior faculty, or established investigator. The LAM Foundation encourages applications from investigators new to LAM research who could contribute their knowledge and expertise.

About: This pilot award provides funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to LAM. The proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in LAM research or development of novel methods, and providing sufficient preliminary data to justify the Foundation’s support. Results from Pilot and Feasibility Grants should have the potential to lead to the submission of applications for funding from other agencies (e.g., NIH). The award is not intended to support the continuation of programs initiated under other granting mechanisms. https://www.thelamfoundation.org/investigators/funding-opportunities/
LAM
LAM Foundation Clinical Research Grant
Amount: $50,000 over 1 years Deadline:
•LOI due June 15, 2026
•Full proposal due September 15, 2026

Eligibility:

•An applicant may be a clinical fellow, clinical instructor, postdoctoral research fellow, postgraduate medical trainee, junior faculty or established investigator.

About: This clinical pilot award generates hypothesis-driven, clinically focused patient centered research that could improve our understanding of novel therapeutic areas of interest, test interventions, or develop clinical research methodologies. The grant is designed to enable research that has the potential to improve an unmet clinical need relevant to the care of LAM patients. A successful application must be feasible within one year and should have a high probability of generating tangible results, such as larger clinical trials, new approaches to or methods to analyze clinical trials, or new data that could be utilized in a natural history database. https://www.thelamfoundation.org/investigators/funding-opportunities/
Research to Prevent Blindness Physician-Scientist Award  Amount: $300,000 over 2 years  Deadline:
• Nominations due June 15, 2026
• Full proposal due July 1, 2026

Eligibility:

Department Chairs (including interim or acting Chairs) from any institution of higher education in the U.S. may nominate multiple candidates per department.
Though multiple candidates can be nominated from one department, only one award per department can be approved.
Candidates must hold a primary academic position as Associate Professor through full Professor (MD, PhD, or MD/PhD) with a primary appointment in a basic science or other relevant department.
Previous recipients of this grant are ineligible.
Candidates must be full-time faculty in their primary appointment department.
Proposed research cannot be funded – previously or currently – by others (NEI, NIH, nonprofits, private funders, etc.).
Candidates declined for this award must wait two years before re-applying for the SI Award. 

About: The RPB Clinician-Scientist Award in Myopia Research will focus on research that seeks to provide a better understanding of the development of myopia and/or how it can be prevented or decelerated. The number of people affected by myopia is now increasing around the world and is projected to affect 50% of the world population by 2050. https://www.rpbusa.org/grants/

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.

STAY CONNECTED

Sign up for the Research Listserv to stay up to date with the latest news and events.

Research 411 Portal

Still Need Help?